Literature DB >> 24298467

Changing Trend in the Antibiotic Resistance Pattern of Pseudomonas Aeruginosa Isolated from Wound Swabs of Out-Patients and in-Patients of a Tertiary Care Hospital.

Noyal Mariya Joseph1, Sheela Devi, P Shashikala, Reba Kanungo.   

Abstract

CONTEXT: Pseudomonas aeruginosa is the most common gram negative bacteria associated with nosocomial infections. Active surveillance of trends in antibiotic resistance of P. aeruginosa is necessary for the selection of appropriate antimicrobial agent for empirical therapy. AIM: To assess the rates of antibiotic resistance and multidrug resistance among P. aeruginosa isolates and to observe the trend in its resistance pattern over a period of 5 years.
MATERIALS AND METHODS: Pseudomonas aeruginosa isolated from wound swabs during January to June 2007 and January to June 2012 were included in the study. Isolates were identified by conventional tests and antibiotic susceptibility was determined by disc diffusion method according to CLSI guidelines.
RESULTS: A total of 307 Pseudomonas aeruginosa isolates were included in the study. Among these isolates, 165 were isolated during Jan-June 2007 and 142 were isolated during Jan-June 2012. Among in-patients, there was a significant reduction in resistance rates of the isolates to ciprofloxacin (49% to 33%), ceftazidime (50% to 33%), meropenem (35% to 19%) and imipenem (28% to 14%) in 2012. Similarly, the rate of MDR Pseudomonas aeruginosa among the in-patients decreased from 37.9% in 2007 to 23.7% in 2012 (p value 0.0241). There was no significant difference in the resistance rates of the isolates from out-patients during the two study periods.
CONCLUSION: There was a significant decreasing trend in the resistance rates of the isolates to ciprofloxacin, ceftazidime, meropenem and imipenem. Reduction in the use of ciprofloxacin could be probable reason for the decreased resistance among P. aeruginosa isolates, which needs to be further investigated.

Entities:  

Keywords:  Antibiogram, Trend; Pseudomonas aeruginosa

Year:  2013        PMID: 24298467      PMCID: PMC3843476          DOI: 10.7860/JCDR/2013/6113.3461

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

1.  Antibiotic selective pressure and development of bacterial resistance.

Authors:  M Kolár; K Urbánek; T Látal
Journal:  Int J Antimicrob Agents       Date:  2001-05       Impact factor: 5.283

2.  Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group.

Authors:  E Bouza; F Garcia-Garrote; E Cercenado; M Marin; M S Diaz
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

3.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

Authors: 
Journal:  Am J Infect Control       Date:  2003-12       Impact factor: 2.918

4.  Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.

Authors:  Ebbing Lautenbach; Mark G Weiner; Irving Nachamkin; Warren B Bilker; Angela Sheridan; Neil O Fishman
Journal:  Infect Control Hosp Epidemiol       Date:  2006-08-21       Impact factor: 3.254

5.  Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

Authors:  David M Livermore
Journal:  Clin Infect Dis       Date:  2002-01-25       Impact factor: 9.079

6.  National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.

Authors:  Marilee D Obritsch; Douglas N Fish; Robert MacLaren; Rose Jung
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

7.  Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.

Authors:  Eun-Jeong Joo; Cheol-In Kang; Young Eun Ha; Seung-Ji Kang; So Yeon Park; Doo Ryeon Chung; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  Microb Drug Resist       Date:  2011-03-07       Impact factor: 3.431

8.  Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes.

Authors:  Ebbing Lautenbach; Marie Synnestvedt; Mark G Weiner; Warren B Bilker; Lien Vo; Jeff Schein; Myoung Kim
Journal:  Infect Control Hosp Epidemiol       Date:  2010-01       Impact factor: 3.254

9.  Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004.

Authors:  Amen Allah Messadi; Thabet Lamia; Bousselmi Kamel; Oueslati Salima; Memmi Monia; Ben Redjeb Saida
Journal:  Burns       Date:  2008-07-10       Impact factor: 2.744

10.  Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.

Authors:  Emile Coetzee; Heinz Rode; Delawir Kahn
Journal:  S Afr J Surg       Date:  2013-05-03       Impact factor: 0.375

View more
  4 in total

1.  Relationship between Antimicrobial Consumption and the Incidence of Antimicrobial Resistance in Escherichia coli and Klebsiella pneumoniae Isolates.

Authors:  Noyal Mariya Joseph; B Bhanupriya; Deepak Gopal Shewade; Belgode Narasimha Harish
Journal:  J Clin Diagn Res       Date:  2015-02-01

2.  Photodynamic antimicrobial activity of new porphyrin derivatives against methicillin resistant Staphylococcus aureus.

Authors:  Hüseyin Taslı; Ayse Akbıyık; Nermin Topaloğlu; Vildan Alptüzün; Sülünay Parlar
Journal:  J Microbiol       Date:  2018-10-24       Impact factor: 3.422

3.  Antibiotic Resistance Properties of Pseudomonas aeruginosa Isolated From Cases of Superficial Infections at the Emergency Unit.

Authors:  Koorosh Ahmadi; Amir Masoud Hashemian; Seyyed Mohsen Pouryaghobi; Reza Akhavan; Sara Rozmina; Ehsan Bolvardi
Journal:  Jundishapur J Microbiol       Date:  2016-01-23       Impact factor: 0.747

4.  The Effect of Infection Control Nurses on the Occurrence of Pseudomonas aeruginosa Healthcare-Acquired Infection and Multidrug-Resistant Strains in Critically-Ill Children.

Authors:  Wei Xu; Linxi He; Chunfeng Liu; Jian Rong; Yongyan Shi; Wenliang Song; Tao Zhang; Lijie Wang
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.